Jianyou Co., Ltd. (603707): Heparin API price bottom stabilizes formulation and continues to expand overseas markets
Jianyou Co., Ltd. (603707): The resumption of results in the third quarter continues the cash out period for overseas biologics
Jianyou Co., Ltd. (603707) 2024 three-quarter report review: Month-on-month improvement in profitability increases biopharmaceutical transformation
Jianyou Co., Ltd. (603707): Profit margin month-on-month repair of non-heparin/macromolecules
Jianyou Co., Ltd. (603707): Continued transformation and entered a new milestone in the internationalization of high-end formulations
Jianyou Co., Ltd. (603707): Prepare biosimilar drugs to be released and start a new process
Jianyou Co., Ltd. (603707): Heparin APIs are under pressure, optimistic about macromolecule exports to create a second growth curve
Jianyou Co., Ltd. (603707): Overseas pharmaceutical companies continue to make efforts to focus on macromolecule business progress
Jianyou Co., Ltd. (603707): Profit improved month-on-month, and price fluctuations in heparin API were further reduced
Jianyou Co., Ltd. (603707): Performance inflection point is about to reach a biosimilar engine
Jianyou Co., Ltd. (603707): Continued transformation and entered a new milestone in the internationalization of high-end formulations
Jianyou Co., Ltd. (603707): Tenglong swaps bird biosimilar drugs ready for delivery
Jianyou Co., Ltd. (603707): Short-term disturbances in heparin APIs reduce rapid expansion of high-end injection clusters overseas
Jianyou Co., Ltd. (603707): Optimistic about growth certainty under international breakthroughs
Jianyou Co., Ltd. (603707): Short-term disturbances will not change long-term growth trends, optimistic about the global development space of formulations
Jianyou Co., Ltd. (603707): Heparin APIs bring short-term disturbances to the internationalization of formulations to drive long-term growth
Jianyou Co., Ltd. (603707) Annual Report Review Report: Formulation exports maintained high growth under pressure due to impairment and low API prices
Jianyou Co., Ltd. (603707): Overall performance continues to be fulfilled under short-term pressure, overseas pharmaceutical exports continue to be fulfilled
Jianyou Co., Ltd. (603707): An international platform for high-end formulations based on China and the US looking at booming global development
Jianyou Co., Ltd. (603707): Inventory depreciation is optimistic about overseas performance
No Data
No Data